the circumstances can be considered a national emergency.
             Due to these concerns, there has been wide spread demand to suspend Bayer's patent and allow for generics version of the drug to be produced. According to federal law, the government can purchase products like ciprofloxacin for official use from other manufacturers, during a health emergency. Under these conditions the governments exempt from paying any compensation to Buyer for suspending its patent. Critics claim that the main reason the United States government opposes to suspend the patent rights of a foreign drug company during a time of emergency is because they are afraid that it would undermine its support for strong patent rights for pharmaceutical firm, a market in which the United States is prominent.
             Many domestic and foreign drug companies have already received quality approval from the Untied States Food and Drug Administration to manufacture Ciprofloxacin. Some of these companies are not only ready to provide the drug within the 60 days time requirement but they are also willing to offer it at a fraction of the price than what Bayer is charging Americans.
             When presented with a case where you must decide on the appropriate course of action to take, you must first identify the key normative issues and the stakeholders involved in the dispute. The shareholders involved in this particular situation are: the citizens of the United States, the American government, Bayer AG, Bayer AG shareholders, Bayer AG competitors and the World Trade Organization.
             It is fair to state that the main concern in this particular situation should be the safety and well being
             ...